pamidronate has been researched along with Hemangioendothelioma in 1 studies
Hemangioendothelioma: A neoplasm derived from blood vessels, characterized by numerous prominent endothelial cells that occur singly, in aggregates, and as the lining of congeries of vascular tubes or channels. Hemangioendotheliomas are relatively rare and are of intermediate malignancy (between benign hemangiomas and conventional angiosarcomas). They affect men and women about equally and rarely develop in childhood. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1866)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brance, ML | 1 |
| Cóccaro, NM | 1 |
| Roitman, P | 1 |
| Castiglioni, A | 1 |
| Agostinis, F | 1 |
| Spense, M | 1 |
| Scheitlin, B | 1 |
| Rene, N | 1 |
| Brun, LR | 1 |
1 review available for pamidronate and Hemangioendothelioma
| Article | Year |
|---|---|
Pseudomyogenic hemangioendothelioma with bone and soft tissue involvement with favorable response to pamidronate: a case report and systematic review of the literature.
Topics: Adult; Bone and Bones; Female; Hemangioendothelioma; Humans; Magnetic Resonance Imaging; Pamidronate | 2022 |